力诺药包
(301188)
| 流通市值：42.63亿 | | | 总市值：42.63亿 |
| 流通股本：2.32亿 | | | 总股本：2.32亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 275,983,006.27 | 1,080,841,711.81 | 830,872,973.77 | 560,801,220.36 |
| 营业收入 | 275,983,006.27 | 1,080,841,711.81 | 830,872,973.77 | 560,801,220.36 |
| 二、营业总成本 | 234,750,548.19 | 1,020,555,627.53 | 764,080,029.44 | 510,538,334.08 |
| 营业成本 | 202,931,144.74 | 875,376,509.53 | 667,398,936.98 | 447,052,729.26 |
| 税金及附加 | 1,655,458.21 | 7,082,780.76 | 5,353,235.77 | 3,586,522.38 |
| 销售费用 | 10,429,359.27 | 48,491,164.64 | 33,890,836.56 | 21,950,391.31 |
| 管理费用 | 6,787,649.47 | 38,538,881.61 | 22,514,537.48 | 14,183,045.38 |
| 研发费用 | 7,289,160.27 | 33,797,074.91 | 22,242,760.16 | 14,954,946.03 |
| 财务费用 | 5,657,776.23 | 17,269,216.08 | 12,679,722.49 | 8,810,699.72 |
| 其中:利息费用 | 6,827,524.6 | 25,775,480.43 | 17,512,494.92 | 12,565,012.52 |
| 其中:利息收入 | 926,202.04 | 6,811,743.57 | 5,091,891.49 | 3,340,376.94 |
| 加:公允价值变动收益 | 522,506.7 | 1,454,305.47 | 705,920.45 | 705,920.45 |
| 加:投资收益 | 2,561,714.1 | 11,776,620.71 | 10,918,320.37 | 7,020,221.14 |
| 资产处置收益 | - | 20,945.09 | - | - |
| 资产减值损失(新) | -1,617,102.15 | -9,515,563.67 | -2,436,864.59 | -1,601,958.67 |
| 信用减值损失(新) | -2,373,380.88 | -1,551,653.69 | -2,081,276.7 | -2,005,474.24 |
| 其他收益 | 4,577,862.8 | 9,644,156.43 | 5,445,781.89 | 3,471,070.94 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 44,904,058.65 | 72,114,894.62 | 79,344,825.75 | 57,852,665.9 |
| 加:营业外收入 | 76,530.01 | 20,251.73 | 41,021.18 | 32,800.05 |
| 减:营业外支出 | 1,294.5 | 686,218.33 | 683,860.73 | 228,462.9 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 44,979,294.16 | 71,448,928.02 | 78,701,986.2 | 57,657,003.05 |
| 减:所得税费用 | 4,455,474.58 | 5,381,332.15 | 8,230,639.38 | 6,371,988.67 |
| 六、净利润 | 40,523,819.58 | 66,067,595.87 | 70,471,346.82 | 51,285,014.38 |
| 持续经营净利润 | 40,523,819.58 | 66,067,595.87 | 70,471,346.82 | 51,285,014.38 |
| 归属于母公司股东的净利润 | 40,523,819.58 | 66,067,595.87 | 70,471,346.82 | 51,285,014.38 |
| (一)基本每股收益 | 0.17 | 0.29 | 0.3 | 0.22 |
| (二)稀释每股收益 | 0.17 | 0.29 | 0.32 | 0.23 |
| 九、综合收益总额 | 40,523,819.58 | 66,067,595.87 | 70,471,346.82 | 51,285,014.38 |
| 归属于母公司股东的综合收益总额 | 40,523,819.58 | 66,067,595.87 | 70,471,346.82 | 51,285,014.38 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-25 | 2024-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |